(Q80735256)

English

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

scientific article published on 23 July 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

lactic acid bacteria

0 references

Philippe Langella

5

object named as

Philippe Langella

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Naima G Cortes-Perez

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

François Lefèvre

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gérard Corthier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Karine Adel-Patient

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Luis G Bermúdez-Humarán

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

23 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

6581-6588

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Potential and opportunities for use of recombinant lactic acid bacteria in human health

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Recombinant Salmonella vaccines for biodefence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

On the safety of lactic acid bacteria from food

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Commensal gut bacteria: mechanisms of immune modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Cell-surface display of E7 antigen from human papillomavirus type-16 inLactococcus lactisand inLactobacillus plantarumusing a new cell-wall anchor from lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Production of human papillomavirus type 16 E7 protein in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Elicitation of the allergic reaction in beta-lactoglobulin-sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Lactic acid bacteria as vaccine delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.06.062

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17675182%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80735256&oldid=2188283101"